161 related articles for article (PubMed ID: 11698341)
41. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
42. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
43. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
44. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
45. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
Xue K; Xu L; Chen S; Ma G; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
[TBL] [Abstract][Full Text] [Related]
46. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
[TBL] [Abstract][Full Text] [Related]
47. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
[TBL] [Abstract][Full Text] [Related]
48. Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.
Terry KL; Titus-Ernstoff L; Garner EO; Vitonis AF; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):187-90. PubMed ID: 12646505
[TBL] [Abstract][Full Text] [Related]
49. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
[TBL] [Abstract][Full Text] [Related]
50. Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer.
Verde Z; Santiago C; Chicharro LM; Reinoso-Barbero L; Tejerina A; Bandrés F; Gómez-Gallego F
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754415
[TBL] [Abstract][Full Text] [Related]
51. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
[TBL] [Abstract][Full Text] [Related]
52. Multiplex PCR with confronting two-pair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T.
Kawai S; Nishio K; Nakamura S; Sekido Y; Niwa T; Hamajima N
Asian Pac J Cancer Prev; 2005; 6(3):346-52. PubMed ID: 16235998
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women.
Miyoshi Y; Takahashi Y; Egawa C; Noguchi S
Breast J; 2002; 8(4):209-15. PubMed ID: 12100112
[TBL] [Abstract][Full Text] [Related]
54. Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese.
Wang B; Wang J; Liu J; Ni F; Yan J; Zhou S; Mu Y; Cao Y; Ma X
Endocrine; 2009 Aug; 36(1):16-9. PubMed ID: 19507064
[TBL] [Abstract][Full Text] [Related]
55. Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Int J Gynecol Cancer; 2011 Feb; 21(2):323-31. PubMed ID: 21270613
[TBL] [Abstract][Full Text] [Related]
56. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans.
Kawamoto T; Koga M; Murata K; Matsuda S; Kodama Y
Toxicol Appl Pharmacol; 1995 Aug; 133(2):295-304. PubMed ID: 7645026
[TBL] [Abstract][Full Text] [Related]
57. CYP1A1, smoking and venous thromboembolism.
Zhu J; Zheng WJ; Kong FC; Zhang WJ; Wang HY; Wang C
Thromb Haemost; 2010 Oct; 104(4):702-8. PubMed ID: 20664892
[TBL] [Abstract][Full Text] [Related]
58. CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.
Idris HME; Khalil HB; Mills J; Elderdery AY
Curr Cancer Drug Targets; 2020; 20(9):675-680. PubMed ID: 32418524
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use.
Kao SY; Wu CH; Lin SC; Yap SK; Chang CS; Wong YK; Chi LY; Liu TY
J Oral Pathol Med; 2002 Oct; 31(9):505-11. PubMed ID: 12269988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
